InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,633.91
(
1.02%
)
US TECH 100
20,118.44
(
1.04%
)
Dow Jones
39,721.36
(
1.09%
)
Brent Oil
84.97
(
0.32%
)
Bitcoin
57,429.99
(
-1.02%
)

Replies to post #38258 on Relief Therapeutics Holding AG (RLFTF)

Replies to #38258 on Relief Therapeutics Holding AG (RLFTF)

elllk

04/13/21 11:17 AM

#38260 RE: ratna1 #38258

A-M301 is primarily for allergic rhinitis and preliminary preclinical data only suggest therapeutic utility post SARS-CoV-2 infection.